+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Neurostimulation Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 180 Pages
  • November 2025
  • Region: Global
  • TechSci Research
  • ID: 5952837
Free Webex Call
10% Free customization

Pain Management is the fastest growing segment, North America is the largest regional market

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Neurostimulation Devices Market, valued at USD 6.07 Billion in 2024, is projected to experience a CAGR of 12.10% to reach USD 12.05 Billion by 2030. Neurostimulation devices are specialized medical technologies that deliver controlled electrical impulses to targeted nerves or neural pathways to modulate activity within the nervous system, offering therapeutic intervention for various chronic conditions. This market is fundamentally driven by the escalating global prevalence of neurological disorders and chronic pain conditions, coupled with an aging worldwide population more susceptible to such ailments. Further impetus comes from the increasing patient and clinician preference for minimally invasive treatment alternatives over conventional pharmacological approaches.

Key Market Drivers

The rising burden of neurological and chronic pain disorders significantly drives the global neurostimulation devices market. An escalating number of individuals afflicted with conditions such as neuropathic pain, epilepsy, and movement disorders creates a substantial and growing patient population requiring advanced therapeutic interventions. Neurostimulation offers a viable alternative or adjunct to pharmacological treatments, which may have efficacy limitations. According to "A global study of pain prevalence across 52 countries: examining the role of country-level contextual factors," published in the journal BMC Public Health in September 2023, the overall unweighted prevalence of reported pain for the total combined sample was 28%. This high disease burden necessitates effective and durable treatment options, directly stimulating the adoption and development of neurostimulation technologies.

Key Market Challenges

The substantial cost associated with neurostimulation devices and their implantation procedures, alongside complex reimbursement landscapes, represents a significant challenging factor. This financial barrier directly hampers the growth of the Global Neurostimulation Devices Market by limiting patient access and adoption. High upfront expenses for both the devices and the specialized surgical procedures render these therapies inaccessible for many individuals and strain healthcare budgets globally.

Key Market Trends

Advanced miniaturization and wireless connectivity are significantly influencing the Global Neurostimulation Devices Market by enhancing patient comfort and discretion. Smaller implants and wireless features reduce invasive procedures and simplify remote management, fostering long-term therapy adherence. This innovative momentum is substantial across medical technology; MedTech Europe reported over 15,700 patent applications filed with the European Patent Office in medical technology in 2024, reflecting sustained growth in device advancements.

Key Market Players Profiled:

  • Boston Scientific Corporation
  • Medtronic PLC
  • Abbott Laboratories Inc.
  • Nevro Corp.
  • Liva Nova PLC
  • Axonics Modulation Technologies Inc.
  • Neuropace Inc.
  • EndoStim Inc.
  • NDI Medical LLC
  • Neuronetics Inc

Report Scope:

In this report, the Global Neurostimulation Devices Market has been segmented into the following categories:

By Type:

  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Others

By Application:

  • Pain Management
  • Hearing Loss
  • Urinary Incontinence
  • Parkinson's Disease
  • Epilepsy
  • Others

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Neurostimulation Devices Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Neurostimulation Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Others)
5.2.2. By Application (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy, Others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Neurostimulation Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Application
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Neurostimulation Devices Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Application
6.3.2. Canada Neurostimulation Devices Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Application
6.3.3. Mexico Neurostimulation Devices Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Application
7. Europe Neurostimulation Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Application
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Neurostimulation Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Application
7.3.2. France Neurostimulation Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Application
7.3.3. United Kingdom Neurostimulation Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Application
7.3.4. Italy Neurostimulation Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Application
7.3.5. Spain Neurostimulation Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Application
8. Asia-Pacific Neurostimulation Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Application
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Neurostimulation Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Application
8.3.2. India Neurostimulation Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Application
8.3.3. Japan Neurostimulation Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Application
8.3.4. South Korea Neurostimulation Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Application
8.3.5. Australia Neurostimulation Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Application
9. Middle East & Africa Neurostimulation Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Neurostimulation Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Application
9.3.2. UAE Neurostimulation Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Application
9.3.3. South Africa Neurostimulation Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Application
10. South America Neurostimulation Devices Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Application
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Neurostimulation Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Application
10.3.2. Colombia Neurostimulation Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Application
10.3.3. Argentina Neurostimulation Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Application
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Neurostimulation Devices Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Boston Scientific Corporation
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Medtronic PLC
15.3. Abbott Laboratories Inc.
15.4. Nevro Corp.
15.5. Liva Nova PLC
15.6. Axonics Modulation Technologies Inc.
15.7. Neuropace Inc.
15.8. EndoStim Inc.
15.9. NDI Medical LLC
15.10. Neuronetics Inc.
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

The companies profiled in this Neurostimulation Devices market report include:
  • Boston Scientific Corporation
  • Medtronic PLC
  • Abbott Laboratories Inc.
  • Nevro Corp.
  • Liva Nova PLC
  • Axonics Modulation Technologies Inc.
  • Neuropace Inc.
  • EndoStim Inc.
  • NDI Medical LLC
  • Neuronetics Inc.

Table Information